Story perspectives

GLP-1 Drugs: Cancer Risks and Promising New Delivery Methods

8/23/2025

30 3

Summary

Story summary

GLP-1 drugs for diabetes and weight loss may reduce overall cancer risk but slightly increase kidney cancer risk.
The UK's MHRA recommends consulting healthcare professionals before changing GLP-1 medications due to rising costs.
New drug delivery methods could enable rapid injections instead of prolonged IV infusions.
Chinese researchers are advancing plant-based microbeads for weight loss, showing positive results in rats and progressing to human trials.

1 of 1

Story summary

GLP-1 drugs for diabetes and weight loss may reduce overall cancer risk but slightly increase kidney cancer risk.
The UK's MHRA recommends consulting healthcare professionals before changing GLP-1 medications due to rising costs.
New drug delivery methods could enable rapid injections instead of prolonged IV infusions.
Chinese researchers are advancing plant-based microbeads for weight loss, showing positive results in rats and progressing to human trials.